Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Early Variations in Immune Aging
Authors not listed
Radboud University Medical Center · 2024
Abstract
Background:
Despite an increase in lifespan over the last decades, our healthspan(definition) lags behind. In our aging population, it is pressing that we prevent age-related morbidities and associated burden on the health care system. Instead of investigating aging in already aged populations, the currently proposed study aims to elucidate the process of immune aging in relation to biological aging, demographic and lifestyle factors in young and midlife adults, and to identify early biomarkers and pathways associated with fast versus slow immune aging and aging endotypes.
Study design:
A single-center, observational prospective cohort study in the Netherlands. Participants from priorly established cohorts will be invited to join the EVIA-study. We will obtain demographic and basic clinical data and biological samples (blood and stool) at baseline and after three years, with a short, yearly online questionnaire in between.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
Anonymous. (2024). Early Variations in Immune Aging. <em>Radboud University Medical Center</em>. https://clinicaltrials.gov/study/NCT06295354
Vancouver
Anonymous. Early Variations in Immune Aging. Radboud University Medical Center. 2024.
BibTeX
@misc{anon2024EarlyV,
title = {Early Variations in Immune Aging},
author = {Anonymous},
journal = {Radboud University Medical Center},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Proceedings of the National Academy of Sciences 2015
Open access · OA
Quantification of biological aging in young adults
F1000Research 2025
Open access · CC-BY
Protocol for a pilot clinical trial of the senolytic drug combination Dasatinib Plus Quercetin to mitigate age-related health and cognitive decline in mental disorders
Biomedicines 2020
Open access · CC-BY
Can Blood-Circulating Factors Unveil and Delay Your Biological Aging?
JCI Insight 2021
Open access · CC-BY
Ketone body β-hydroxybutyrate is an autophagy-dependent vasodilator
International Journal of Molecular Sciences 2024
Open access · CC-BY
The Role of Molecular and Cellular Aging Pathways on Age-Related Hearing Loss
Experimental Gerontology 2003
Open access · CC0